Clinical Trial Update: A Post-Approval Pharmacokinetic Study of Bortezomib in Participants With Multiple Myeloma [Phase 3]

View source ↗

Summary

This Phase 3 clinical trial update reports pharmacokinetic data for bortezomib in participants with multiple myeloma, conducted after initial approval.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Myeloma

Drugs mentioned

• Velcade (bortezomib)

Snippet

Sponsor: Johnson & Johnson Taiwan Ltd | Conditions: Multiple Myeloma | Phase 3 | Status: COMPLETED | Results posted: 2013-05-16